These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8991669)

  • 1. [Endocrine function of the pancreas in patients with organic hyperinsulinism syndrome].
    Lifshits IuZ; Usenko AIu; Kozhara SP; Furmanenko ED
    Klin Khir; 1996; (5):10-1. PubMed ID: 8991669
    [No Abstract]   [Full Text] [Related]  

  • 2. [Diagnosis of organic hyperinsulinism].
    Arnold R; Rothmund M
    Dtsch Med Wochenschr; 1989 Mar; 114(12):464-7. PubMed ID: 2538302
    [No Abstract]   [Full Text] [Related]  

  • 3. [Parameters of carbohydrate metabolism in patients before and after removal of insulinoma].
    Trofimov VM; Mazurov VI; Arkhipov VF; Klimko NN
    Probl Endokrinol (Mosk); 1993; 39(1):30-3. PubMed ID: 8058659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ineffectiveness of SMS 201-995 in severe hyperinsulinemia.
    Boden G; Ryan IG; Shuman CR
    Diabetes Care; 1988 Sep; 11(8):664-8. PubMed ID: 3065005
    [No Abstract]   [Full Text] [Related]  

  • 5. A hyperinsulinaemic, sequentially eu- and hypoglycaemic clamp test to characterize autonomous insulin secretion in patients with insulinoma.
    Nauck MA; Baum F; Seidensticker F; Røder M; Dinesen B; Creutzfeldt W
    Eur J Clin Invest; 1997 Feb; 27(2):109-15. PubMed ID: 9061303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucagon-insulin interactions in patients with insulin-producing pancreatic islet lesions.
    Cloutier MG; Pek S; Crowther RL; Floyd JC; Faians SS
    J Clin Endocrinol Metab; 1979 Feb; 48(2):201-6. PubMed ID: 372202
    [No Abstract]   [Full Text] [Related]  

  • 7. C-peptide during the prolonged fast in insulinoma.
    Service FJ; O'Brien PC; McMahon MM; Kao PC
    J Clin Endocrinol Metab; 1993 Mar; 76(3):655-9. PubMed ID: 8445021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The C-peptide suppression test in normal persons and insulinoma patients: an attempt to evaluate its use in functional diagnosis (author's transl)].
    Mandelkow H; Goetz K; Kühnau J
    Klin Wochenschr; 1981 Nov; 59(21):1209-15. PubMed ID: 6273644
    [No Abstract]   [Full Text] [Related]  

  • 9. Hyperinsulinaemia and blood pressure in patients with insulinoma.
    Fujita N; Baba T; Tomiyama T; Kodama T; Kako N
    BMJ; 1992 May; 304(6835):1157. PubMed ID: 1392796
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical presentation in insulinoma predicts histopathological tumour characteristics.
    Wolf P; Winhofer Y; Smajis S; Anderwald CH; Scheuba C; Niederle B; Gessl A; Luger A; Krebs M; Koperek O
    Clin Endocrinol (Oxf); 2015 Jul; 83(1):67-71. PubMed ID: 25817061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asymptomatic insulinoma: a case report and autopsy series.
    Kishi S; Sakamoto K; Mori M; Isogawa A; Shiba T
    Diabetes Res Clin Pract; 2012 Dec; 98(3):445-51. PubMed ID: 23084041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Organic hyperinsulinism in advanced age].
    Wolken D; Thon KP
    Chirurg; 1993 Oct; 64(10):832-4. PubMed ID: 8269752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pancreatic beta cell function and the C-peptide content in the blood serum in thyrotoxicosis].
    Pavliuk PM; Slavnov VN; Epshteĭn EV
    Klin Med (Mosk); 1982 Apr; 60(4):51-4. PubMed ID: 7047893
    [No Abstract]   [Full Text] [Related]  

  • 14. C-peptide measurement and its clinical usefulness: a review.
    Bonser AM; Garcia-Webb P
    Ann Clin Biochem; 1981 Jul; 18(Pt 4):200-6. PubMed ID: 7025733
    [No Abstract]   [Full Text] [Related]  

  • 15. Assessment of hyperinsulinaemia at the termination of the prolonged fast.
    Wiesli P; Brändle M; Zapf J; Seiler H; Zwimpfer C; Spinas GA; Schmid C
    Clin Chim Acta; 2004 Apr; 342(1-2):227-31. PubMed ID: 15026285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnosis of insulinomas. Determination of insulin, C-peptide and proinsulin in blood to differentiate between endogenous and exogenous hyperinsulinism].
    Hanssen KF; Torjesen PA; Heding LG
    Tidsskr Nor Laegeforen; 1981 Dec; 101(34-36):1957-60. PubMed ID: 6280336
    [No Abstract]   [Full Text] [Related]  

  • 17. Insulin surrogates in insulinoma.
    O'Brien T; O'Brien PC; Service FJ
    J Clin Endocrinol Metab; 1993 Aug; 77(2):448-51. PubMed ID: 8345050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Features of incretory function of the pancreas in patients with insulinoma].
    Furmanenko ED; Dubitskiĭ AE; Kozhara SP
    Ter Arkh; 1988; 60(9):63-6. PubMed ID: 2851189
    [No Abstract]   [Full Text] [Related]  

  • 19. [Insulinoma: experience in our hospital].
    DiDio F; Morel P; Rohner A
    Schweiz Med Wochenschr; 1994 Jul; 124(27-28):1248-52. PubMed ID: 8052830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin, C-peptide and proinsulin for the biochemical diagnosis of hypoglycaemia related to endogenous hyperinsulinism.
    Vezzosi D; Bennet A; Fauvel J; Caron P
    Eur J Endocrinol; 2007 Jul; 157(1):75-83. PubMed ID: 17609405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.